[1] 黄英.二甲双胍联合多烯磷脂酰胆碱对非酒精性脂肪肝的疗效观察 [J].中国伤残医学,2015,7(1):17-19. [2] Evan J, Donny K, Joseph R,et al. Diabetes mellitus pre-dicts occurrence of cirrhosis and hepatocellular cancer in al-coholic liver and non- alcoholic fatty liver diseases [J]. J Clin Transl Hepatol,2015,3(1):9-16. [3] 余娇,王伟.多烯磷脂酰胆碱对急性肝损伤患者血清NO、NOS水平 的影响[J].肝脏,2018,23(3):269-270. [4] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性 肝病诊疗指南[J].中华肝脏病杂志,2010,18(30):163-166. [5] Han Y, Lin M, Wang X,et al. Basis of aggravated hepat-ic lipid metabolism by chronic stress in high-fat diet-fed rat [J]. Endocrine, 2015,48(2):483-492. [6] 叶非,包剑锋,陈蓉等.多烯磷脂酰胆碱联合二甲双胍治疗非酒精 性脂肪肝的疗效观察[J].中国现代医生,2015,53(17):102-104. [7] 黄静,陈湘清,郭东升等.多烯磷脂酰胆碱联合二甲双胍治疗非酒精 性脂肪肝的疗效[J].中国老年学杂志,2017,37(24):6127-6129 [8] 李世媛,胡定海.多烯磷脂酰胆碱联合二甲双胍治疗非酒精性脂肪 肝的疗效观察[J].中国医药指南,2017,15(8):93.